Identifying Regulators of APP Metabolism in Alzheimer's Disease
Author Information
Author(s): Zhang Can, Khandelwal Preeti J, Chakraborty Ranjita, Cuellar Trinna L, Sarangi Srikant, Patel Shyam A, Cosentino Christopher P, O'Connor Michael, Lee Jeremy C, Tanzi Rudolph E, Saunders Aleister J
Primary Institution: Drexel University
Hypothesis
Can we develop a genetic screen to identify regulators of APP metabolism using an AICD-based functional assay?
Conclusion
The study demonstrates that Ubiquilin 1 regulates APP metabolism and can be identified as a regulator using the AICD-Gal4 mediated luciferase assay.
Supporting Evidence
- The AICD-Gal4 mediated luciferase assay accurately reflects changes in APP metabolism.
- Ubiquilin 1 was shown to modulate APP levels and PS1 endoproteolysis.
- Pharmacologic modulation of secretase activities resulted in predictable changes in luciferase activity.
Takeaway
Researchers created a test to find out how certain proteins affect the processing of a protein linked to Alzheimer's disease, and they found that Ubiquilin 1 plays an important role.
Methodology
The study used an AICD-Gal4 mediated luciferase assay in SH-SY5Y neuroblastoma cells to identify regulators of APP metabolism through pharmacologic and genetic manipulation.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website